Nutra Pharma Corp. (NPHC)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jun 1, 2026, 9:30 AM EST
Nutra Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.02 | 0.01 | 0.04 | - | - | 0.09 |
Short-Term Investments | 0.02 | 0.02 | 0.02 | 0.04 | - | - |
Cash & Short-Term Investments | 0.04 | 0.03 | 0.05 | 0.04 | - | 0.09 |
Cash Growth | 25.45% | -44.90% | 53.54% | - | - | - |
Accounts Receivable | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | 0.05 |
Other Receivables | 0.13 | 0.13 | 0.08 | 0.04 | - | 0.01 |
Receivables | 0.21 | 0.21 | 0.11 | 0.07 | 0.25 | 0.33 |
Inventory | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
Prepaid Expenses | 0.06 | 0.03 | 0.03 | 0.03 | 0.06 | 0.07 |
Other Current Assets | 0.16 | 0.16 | 0.16 | 0.16 | - | 0.02 |
Total Current Assets | 0.5 | 0.46 | 0.37 | 0.31 | 0.33 | 0.53 |
Property, Plant & Equipment | 0.02 | 0.03 | 0.1 | 0.19 | 0.33 | 0.14 |
Other Long-Term Assets | 0.09 | 0.1 | 0.12 | 0.13 | 0.09 | 0.11 |
Total Assets | 0.62 | 0.58 | 0.6 | 0.64 | 0.75 | 0.78 |
Accounts Payable | 0.84 | 0.85 | 0.8 | 0.76 | 0.73 | 0.67 |
Accrued Expenses | 4.36 | 3.56 | 3.25 | 2.76 | 2.36 | 2.05 |
Short-Term Debt | 1.69 | 3.86 | 3.51 | 2.75 | 2.07 | 3.28 |
Current Portion of Long-Term Debt | 9.87 | 7.35 | 6.22 | 6.24 | 5.98 | 4.52 |
Current Portion of Leases | - | - | 0.09 | 0.08 | 0.07 | 0.08 |
Current Unearned Revenue | - | - | - | 0.23 | 0.18 | - |
Other Current Liabilities | 0.98 | 1.64 | 1.39 | 1.34 | 1.31 | 10.54 |
Total Current Liabilities | 17.74 | 17.27 | 15.27 | 14.17 | 12.7 | 21.14 |
Long-Term Debt | 0.14 | 0.14 | 0.14 | 0.14 | 0.25 | 0.52 |
Long-Term Leases | - | - | - | 0.09 | 0.18 | - |
Total Liabilities | 17.88 | 17.41 | 15.41 | 14.41 | 13.13 | 21.66 |
Common Stock | 7.16 | 7.1 | 7.1 | 7.06 | 7.04 | 6.77 |
Additional Paid-In Capital | 53.79 | 53.84 | 53.84 | 53.63 | 53.65 | 53.6 |
Retained Earnings | -78.74 | -78.28 | -76.23 | -74.95 | -73.55 | -81.73 |
Comprehensive Income & Other | 0.51 | 0.5 | 0.47 | 0.47 | 0.47 | 0.47 |
Total Common Equity | -17.27 | -16.84 | -14.82 | -13.78 | -12.39 | -20.89 |
Shareholders' Equity | -17.26 | -16.83 | -14.81 | -13.77 | -12.38 | -20.88 |
Total Liabilities & Equity | 0.62 | 0.58 | 0.6 | 0.64 | 0.75 | 0.78 |
Total Debt | 11.69 | 11.35 | 9.96 | 9.31 | 8.55 | 8.4 |
Net Cash (Debt) | -11.65 | -11.32 | -9.91 | -9.27 | -8.55 | -8.3 |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 7,160 | 7,160 | 7,160 | 7,100 | 7,100 | 7,364 |
Total Common Shares Outstanding | 7,160 | 7,100 | 7,100 | 7,065 | 7,040 | 7,331 |
Working Capital | -17.24 | -16.81 | -14.89 | -13.86 | -12.37 | -20.61 |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Tangible Book Value | -17.27 | -16.84 | -14.82 | -13.78 | -12.39 | -20.89 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Machinery | - | 0.08 | 0.06 | 0.06 | 0.25 | 0.19 |
Leasehold Improvements | - | - | - | - | 0.07 | 0.07 |